Labeler
Prasco Laboratories NDC Codes
Prasco Laboratories lists 105 finished drug products in the FDA NDC Directory under NDC labeler code 66993.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Amlodipine and Atorvastatin, Dasatinib, Conjugated Estrogens, Testosterone, phentermine and topiramate, Mirtazapine, Fluticasone Furoate Ellipta, Fluticasone Propionate Diskus, Fluticasone Propionate and Salmeterol HFA, Fluticasone Propionate HFA, Prazosin Hydrochloride, Fluticasone Propionate and Salmeterol DISKUS, Lanthanum carbonate, Nisoldipine, Teriparatide
- Active ingredients
- Fluticasone propionate, Amlodipine besylate, Atorvastatin calcium trihydrate, Dasatinib, Salmeterol xinafoate, Estrogens, Conjugated, Fluticasone furoate, Testosterone, Phentermine hydrochloride, Topiramate, Dapagliflozin propanediol, Mirtazapine
- NDC labeler codes
- 66993
- Strengths (from the 100 most recently listed products)
- Amlodipine besylate 5 mg/1; Amlodipine besylate 10 mg/1; Vilanterol trifenatate 25 ug/1; Salmeterol xinafoate 21 ug/1; Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1; Atorvastatin calcium trihydrate 40 mg/1; Salmeterol xinafoate 50 ug/1; Umeclidinium bromide 62.5 ug/1; Fluticasone furoate 100 ug/1; Fluticasone furoate 200 ug/1; Teriparatide 250 ug/mL; Testosterone 16.2 mg/g; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 1000 mg/1; Fluticasone propionate 100 ug/1; Fluticasone propionate 250 ug/1; Atorvastatin calcium trihydrate 80 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Coated, Powder, Tablet, Aerosol, Metered, Capsule, Extended release, Gel, Tablet, Film coated, Extended release, Capsule, Tablet, Chewable, Spray, Powder, Metered, Ointment, Injection, Solution, Tablet, For suspension, Injection, Suspension, Cream, Solution, Aerosol, Powder, Solution/ drops, Suspension, Insert, Extended release
- Routes
- Oral, Respiratory (Inhalation), Transdermal, Topical, Subcutaneous, Intramuscular, Vaginal, Nasal, Ophthalmic, Intravenous
- Drug classes (FDA established)
- Corticosteroid, Dihydropyridine Calcium Channel Blocker, Calcium Channel Blocker, HMG-CoA Reductase Inhibitor, beta2-Adrenergic Agonist, Central Nervous System Stimulant, Estrogen, Kinase Inhibitor, Androgen, Sympathomimetic Amine Anorectic, Sodium-Glucose Cotransporter 2 Inhibitor, alpha-Adrenergic Blocker, Progestin, Phosphate Binder, Anticholinergic, Parathyroid Hormone Analog, Biguanide, Serotonin-1b and Serotonin-1d Receptor Agonist, Vitamin D Analog, Potassium-sparing Diuretic, Renin Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Peroxisome Proliferator Receptor gamma Agonist, Sulfonylurea, Thiazolidinedione, Antimalarial, Nitrate Vasodilator, Prostaglandin Analog, Dihydrofolate Reductase Inhibitor Antibacterial, Sulfonamide Antimicrobial, Aldosterone Antagonist, Thiazide Diuretic, Anti-epileptic Agent, Nonsteroidal Anti-inflammatory Drug, Antiprotozoal, Nitroimidazole Antimicrobial
- HCPCS / J-code
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- Package NDCs
- 113 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Fluticasone Furoate and Vilanterol | Fluticasone furoate 100 ug/1; Vilanterol trifenatate 25 ug/1 | PowderRespiratory (Inhalation) | 66993-135 | 66993-0135-97 | — |
| Fluticasone Furoate and Vilanterol | Fluticasone furoate 200 ug/1; Vilanterol trifenatate 25 ug/1 | PowderRespiratory (Inhalation) | 66993-136 | 66993-0136-97 | — |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | 66993-730 | 66993-0730-0266993-0730-80 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, CoatedOral | 66993-263 | 66993-0263-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, CoatedOral | 66993-264 | 66993-0264-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, CoatedOral | 66993-265 | 66993-0265-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, CoatedOral | 66993-266 | 66993-0266-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, CoatedOral | 66993-267 | 66993-0267-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, CoatedOral | 66993-268 | 66993-0268-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, CoatedOral | 66993-269 | 66993-0269-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, CoatedOral | 66993-270 | 66993-0270-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, CoatedOral | 66993-271 | 66993-0271-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, CoatedOral | 66993-272 | 66993-0272-30 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, CoatedOral | 66993-273 | 66993-0273-30 | — |
| Prazosin Hydrochloride | Prazosin hydrochloride 5 mg/1 | CapsuleOral | 66993-433 | 66993-0433-85 | — |
| Prazosin Hydrochloride | Prazosin hydrochloride 2 mg/1 | CapsuleOral | 66993-432 | 66993-0432-85 | — |
| Spironolactone and Hydrochlorothiazide | Spironolactone 25 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 66993-188 | 66993-0188-02 | — |
| Phenytoin Infatabsphenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | 66993-372 | 66993-0372-02 | — |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | 66993-371 | 66993-0371-79 | J1050 |
| Estradiol Vaginal Creamestradiol | Estradiol .1 mg/g | CreamVaginal | 66993-002 | 66993-0002-10 | — |
| Prazosin Hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | 66993-431 | 66993-0431-85 | — |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | 66993-370 | 66993-0370-2566993-0370-83 | J1050 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | 66993-897 | 66993-0897-1566993-0897-49 | — |
| Etonogestrel/Ethinyl Estradioletonogestrel and ethinyl estradiol | Etonogestrel .12 mg/d; Ethinyl estradiol .015 mg/d | Insert, Extended releaseVaginal | 66993-605 | 66993-0605-36 | — |
| Sumatriptan | Sumatriptan 5 mg/100uL | SprayNasal | 66993-081 | 66993-0081-69 | — |
| Sumatriptan | Sumatriptan 20 mg/100uL | SprayNasal | 66993-082 | 66993-0082-69 | — |
| Calcipotriene and Betamethasone Dipropionate | Calcipotriene monohydrate 50 ug/g; Betamethasone dipropionate .5 mg/g | OintmentTopical | 66993-938 | 66993-0938-6166993-0938-65 | — |
| triamterene | Triamterene 50 mg/1 | CapsuleOral | 66993-831 | 66993-0831-02 | — |
| Triamterene | Triamterene 100 mg/1 | CapsuleOral | 66993-832 | 66993-0832-02 | — |
| Aliskirenaliskiren hemifumarate | Aliskiren hemifumarate 150 mg/1 | Tablet, Film coatedOral | 66993-141 | 66993-0141-30 | — |
| Aliskirenaliskiren hemifumarate | Aliskiren hemifumarate 300 mg/1 | Tablet, Film coatedOral | 66993-142 | 66993-0142-30 | — |
| Fluticasone Propionate and Salmeterol DISKUSfluticasone propionate and salmeterol | Fluticasone propionate 100 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 66993-584 | 66993-0584-97 | — |
| Fluticasone Propionate and Salmeterol DISKUSfluticasone propionate and salmeterol | Fluticasone propionate 250 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 66993-585 | 66993-0585-97 | — |
| Fluticasone Propionate and Salmeterol DISKUSfluticasone propionate and salmeterol | Fluticasone propionate 500 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 66993-586 | 66993-0586-97 | — |
| Albuterol Sulfate HFAalbuterol sulfate | Albuterol sulfate 90 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | 66993-019 | 66993-0019-68 | — |
| Lanthanum carbonate | Lanthanum carbonate 500 mg/1 | Tablet, ChewableOral | 66993-422 | 66993-0422-85 | — |
| Lanthanum carbonate | Lanthanum carbonate 750 mg/1 | Tablet, ChewableOral | 66993-423 | 66993-0423-85 | — |
| Lanthanum carbonate | Lanthanum carbonate 1000 mg/1 | Tablet, ChewableOral | 66993-424 | 66993-0424-85 | — |
| Ibuprofen Lysine | Ibuprofen lysine 10 mg/mL | SolutionIntravenous | 66993-490 | 66993-0490-36 | — |
| pioglitazone and glimepiride | Pioglitazone hydrochloride 30 mg/1; Glimepiride 2 mg/1 | TabletOral | 66993-821 | 66993-0821-30 | — |
| pioglitazone and glimepiride | Pioglitazone hydrochloride 30 mg/1; Glimepiride 4 mg/1 | TabletOral | 66993-822 | 66993-0822-30 | — |
| Dextroamphetamine Sulfate | Dextroamphetamine sulfate 5 mg/5mL | SolutionOral | 66993-359 | 66993-0359-57 | — |
| calcipotriene | Calcipotriene 50 ug/g | OintmentTopical | 66993-878 | 66993-0878-6166993-0878-78 | — |
| Atovaquone and Proguanil HClatovaquone and proguanil hydrochloride | Atovaquone 250 mg/1; Proguanil hydrochloride 100 mg/1 | Tablet, Film coatedOral | 66993-060 | 66993-0060-0266993-0060-27 | — |
| Nisoldipine | Nisoldipine 8.5 mg/1 | Tablet, Film coated, Extended releaseOral | 66993-472 | 66993-0472-02 | — |
| Nisoldipine | Nisoldipine 17 mg/1 | Tablet, Film coated, Extended releaseOral | 66993-473 | 66993-0473-02 | — |
| Nisoldipine | Nisoldipine 34 mg/1 | Tablet, Film coated, Extended releaseOral | 66993-475 | 66993-0475-02 | — |
| Metronidazole | Metronidazole 7.5 mg/g | CreamTopical | 66993-960 | 66993-0960-45 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfatedextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 1.25 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | 66993-594 | 66993-0594-02 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfatedextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 2.5 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | 66993-595 | 66993-0595-02 | — |
Prasco Laboratories: common questions
- What is Prasco Laboratories's NDC labeler code?
- 66993. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Prasco Laboratories?
- Med-Code's HCPCS directory matches J1050 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.